Terrence Keaney, MD

Founder and Director
SkinDC

Disclosure information not submitted.

Presentation(s):

• Proactive Treatment Approach and Timing Patients on GLP-1 Agonists: What and When to Treat with Nonsurgical Aesthetic Procedures

  Thursday, May 14, 2026
  3:30 PM - 3:40 PM CT

• Panel Discussion – GLP-1/Medical Derm Potpourri

  Thursday, May 14, 2026
  3:40 PM - 4:00 PM CT

• The Neurotoxin Pipeline: From Type E to Liquid Toxins

  Friday, May 15, 2026
  9:20 AM - 9:30 AM CT

• Panel Discussion – Injectables in 2026

  Friday, May 15, 2026
  9:40 AM - 9:50 AM CT

• All About PDGF: Is This The Active Ingredient in PRP?

  Friday, May 15, 2026
  2:55 PM - 3:05 PM CT

• Panel Discussion – Regenerative

  Friday, May 15, 2026
  3:35 PM - 3:45 PM CT

• High Treatment Satisfaction, Natural Looking Results, and Improved Appearance-Related Psychosocial Impact from TrenibotulinumtoxinE Treatment for Glabellar Lines: Pooled Patient Reported Outcomes from 2 Pivotal Phase 3 Trials

  Friday, May 15, 2026
  5:40 PM - 5:45 PM CT

• Panel Discussion- Hot Topics

  Friday, May 15, 2026
  5:55 PM - 6:00 PM CT